Prof. Dr. med. Thomas Hundsberger
chief of service
Neurologie, Medizinische Onkologie und Hämatologie · Dept. III, Dept. I
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.
Schoser B, van der Beek N, Broomfield A, Brusse E, Diaz-Manera J, Hahn A, Hundsberger T, Kornblum C, Kruijshaar M, Laforet P, Mengel E, Mongini T, Orlikowski D, Parenti G, Pijnappel W, Roberts M, Scherer T, Toscano A, Vissing J, O'Sullivan J, van Doorn P, Wenninger S, van der Ploeg A. Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. Eur J Neurol 2024:e16383.
Jun 14, 2024Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.
Jun 14, 2024Eur J Neurol 2024:e16383
Schoser Benedikt, van der Beek Nadine A M E, Broomfield Alexander, Brusse Esther, Diaz-Manera Jordi, Hahn Andreas, Hundsberger Thomas, Kornblum Cornelia, Kruijshaar Michelle E, Laforet Pascal, Mengel Eugen, Mongini Tiziana, Orlikowski David, Parenti Giancarlo, Pijnappel W W M Pim, Roberts Mark, Scherer Thomas, Toscano Antonio, Vissing John, O'Sullivan Joe M, van Doorn Pieter A, Wenninger Stephan, van der Ploeg Ans T
Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment.
Wagner F, Almeida G, Willems E, Weber J, Geiss J, Hundsberger T, Mordasini P, Wildermuth S, Leschka S, Wälti S, Dietrich T, Fischer T. Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment. Insights Imaging 2024; 15:140.
Jun 9, 2024Temporal evolution of primary angiitis of the central nervous system (PACNS) on MRI following immunosuppressant treatment.
Jun 9, 2024Insights Imaging 2024; 15:140
Wagner Franca, Almeida Gonçalo G, Willems Erik, Weber Johannes, Geiss Johannes, Hundsberger Thomas, Mordasini Pasquale, Wildermuth Simon, Leschka Sebastian, Wälti Stephan, Dietrich Tobias Johannes, Fischer Tim Steffen
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.
Mastall M, Roth P, Bink A, Maranta A, Läubli H, Hottinger A, Hundsberger T, Migliorini D, Ochsenbein A, Seystahl K, Imbach L, Hortobágyi T, Held L, Weller M, Wirsching H. A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol. BMC cancer 2024; 24:82.
Jan 15, 2024A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.
Jan 15, 2024BMC cancer 2024; 24:82
Mastall Maximilian, Roth Patrick, Bink Andrea, Maranta Angela Fischer, Läubli Heinz, Hottinger Andreas Felix, Hundsberger Thomas, Migliorini Denis, Ochsenbein Adrian F, Seystahl Katharina, Imbach Lukas L, Hortobágyi Tibor, Held Leonhard, Weller Michael, Wirsching Hans-Georg
Laser Interstitial Thermal Therapy in a large thalamic glioma with long-term remission: A case report.
Hoyningen A, Koster K, Neidert M, Bozinov O, Lauber A, Kim O, Hundsberger T, Krüger M. Laser Interstitial Thermal Therapy in a large thalamic glioma with long-term remission: A case report. Oncol Res Treat 2023
Dec 26, 2023Laser Interstitial Thermal Therapy in a large thalamic glioma with long-term remission: A case report.
Dec 26, 2023Oncol Res Treat 2023
Hoyningen Alexander, Koster Kira-Lee, Neidert Marian Christoph, Bozinov Oliver, Lauber Arno, Kim Olaf Chan-Hi, Hundsberger Thomas, Krüger Marie Therese
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Stadler C, Gramatzki D, Le Rhun E, Hottinger A, Hundsberger T, Roelcke U, Läubli H, Hofer S, Seystahl K, Wirsching H, Weller M, Roth P. Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older. Neurooncol Pract 2023; 11:132-141.
Oct 20, 2023Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
Oct 20, 2023Neurooncol Pract 2023; 11:132-141
Stadler Christina, Gramatzki Dorothee, Le Rhun Emilie, Hottinger Andreas Felix, Hundsberger Thomas, Roelcke Ulrich, Läubli Heinz, Hofer Silvia, Seystahl Katharina, Wirsching Hans-Georg, Weller Michael, Roth Patrick
Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.
Ripellino P, Lascano A, Scheidegger O, Schilg-Hafer L, Schreiner B, Tsouni P, Vicino A, Peyer A, Humm A, Décard B, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C. Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study. Eur J Neurol 2023; 31:e16030.
Aug 25, 2023Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study.
Aug 25, 2023Eur J Neurol 2023; 31:e16030
Ripellino Paolo, Lascano Agustina Maria, Scheidegger Olivier, Schilg-Hafer Lenka, Schreiner Bettina, Tsouni Pinelopi, Vicino Alex, Peyer Anne-Kathrin, Humm Andrea Monika, Décard Bernhard Friedrich, Pianezzi Enea, Zezza Giulia, Sparasci Davide, Hundsberger Thomas, Dietmann Anelia, Jung Hans H, Kuntzer Thierry, Wilder-Smith Einar, Martinetti-Lucchini Gladys, Petrini Orlando, Fontana Stefano, Gowland Peter, Niederhauser Christoph, Gobbi Claudio
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Schmitt C, Hoefsmit E, Fangmeier T, Kramer N, Kabakci C, González-Navajas J, Versluis J, Compter A, Harrer T, Mijočević H, Schubert S, Hundsberger T, Menzies A, Scolyer R, Long G, French L, Blank C, Heinzerling L. Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections. Cancer Immunol Immunother 2023
Aug 22, 2023Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections.
Aug 22, 2023Cancer Immunol Immunother 2023
Schmitt Christina, Hoefsmit E P, Fangmeier T, Kramer N, Kabakci C, González-Navajas Jose M, Versluis Judith M, Compter Annette, Harrer T, Mijočević H, Schubert Steffen, Hundsberger Thomas, Menzies A M, Scolyer Richard A, Long Georgina V, French Lars Einar, Blank Christian U, Heinzerling Lucie M
Immune checkpoint inhibitors induced side effects of the peripheral nervous system.
Hundsberger T, Schreiner B, Roth P. Immune checkpoint inhibitors induced side effects of the peripheral nervous system. Curr Opin Neurol 2023; 36:427-431.
Jul 24, 2023Immune checkpoint inhibitors induced side effects of the peripheral nervous system.
Jul 24, 2023Curr Opin Neurol 2023; 36:427-431
Hundsberger Thomas, Schreiner Bettina, Roth Patrick
Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K, NAMACO Study Group, Swiss HIV Cohort Study. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study. J Acquir Immune Defic Syndr 2023; 93:219-228.
Jul 1, 2023Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Jul 1, 2023J Acquir Immune Defic Syndr 2023; 93:219-228
Filippidis Paraskevas, Damas José, Viala Benjamin, Assal Frédéric, Tshikung Olivier Nawej, Tarr Philip X00a0 E, Derfuss Tobias, Oberholzer Michael, Jelcic Ilijas, Hundsberger Thomas, Sacco Leonardo, Cavassini Matthias, Du Pasquier Renaud A, Darling Katharine Elizabeth Anna, NAMACO Study Group, Swiss HIV Cohort Study
Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study.
Jenny C, van der Linde J, Hundsberger T, Broser P. Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study. Brain Behav 2023; 13:e2944.
Mar 22, 2023Correlation between age and the sciatic nerve diameter in the first 2 years of life: A high-resolution ultrasound study.
Mar 22, 2023Brain Behav 2023; 13:e2944
Jenny Carole, van der Linde Jacoba, Hundsberger Thomas, Broser Philip Julian
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Jörger M, Hundsberger T, Haefliger S, von Moos R, Hottinger A, Kaindl T, Engelhardt M, Marszewska M, Lane H, Roth P, Stathis A. Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Invest New Drugs 2023; 41:267-275.
Feb 16, 2023Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
Feb 16, 2023Invest New Drugs 2023; 41:267-275
Jörger Markus, Hundsberger Thomas, Haefliger Simon, von Moos Roger, Hottinger Andreas F, Kaindl Thomas, Engelhardt Marc, Marszewska Michalina, Lane Heidi, Roth Patrick, Stathis Anastasios
Laser Interstitial Thermal Therapy for Radionecrosis.
Terrapon A, Krüger M, Hundsberger T, Neidert M, Bozinov O. Laser Interstitial Thermal Therapy for Radionecrosis. Neurosurg Clin N Am 2023; 34:209-225.
Jan 31, 2023Laser Interstitial Thermal Therapy for Radionecrosis.
Jan 31, 2023Neurosurg Clin N Am 2023; 34:209-225
Terrapon Alexis Paul Romain, Krüger Marie Therese, Hundsberger Thomas, Neidert Marian Christoph, Bozinov Oliver
Von-Hippel-Lindau-Erkrankung
Koster K, Rothermundt C, Binet F, Borovicka J, Bozinov O, Clerici T, Engeler D, Greiner J, Hader C, Heinimann K, Azzarello-Burri S, Lang C, Krull I, Stöckli S, Omlin A, Hundsberger T. Von-Hippel-Lindau-Erkrankung - Interdisziplinäre Betreuung und neue therapeutische Optionen. Swiss Med Forum 2022; 48:4-784-787.
Nov 30, 2022Von-Hippel-Lindau-Erkrankung
Nov 30, 2022Swiss Med Forum 2022; 48:4-784-787
Koster Kira-Lee, Rothermundt Christian, Binet Françoise-Isabelle, Borovicka Jan, Bozinov Oliver, Clerici Thomas, Engeler Daniel, Greiner J, Hader Claudia, Heinimann Karl, Azzarello-Burri Silvia, Lang Corina, Krull Ina, Stöckli Sandro, Omlin Aurelius, Hundsberger Thomas
Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Müller-Jensen L, Zierold S, Versluis J, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank C, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel J, Ugurel S, Zimmer L, Banks P, Spain L, Soon J, Enokida T, Tahara M, Kähler K, Seggewiss-Bernhardt R, Harvey C, Long G, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French L, Knauss S, Heinzerling L. Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis. Data Brief 2022; 45:108649.
Sep 30, 2022Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis.
Sep 30, 2022Data Brief 2022; 45:108649
Müller-Jensen Leonie, Zierold Sarah, Versluis Judith M, Boehmerle Wolfgang, Huehnchen Petra, Endres Matthias, Mohr Raphael, Compter Annette, Blank Christian U, Hagenacker Tim, Meier Friedegund, Reinhardt Lydia, Gesierich Anja, Salzmann Martin, Hassel Jessica C, Ugurel Selma, Zimmer Lisa, Banks Patricia, Spain Lavinia, Soon Jennifer A, Enokida Tomohiro, Tahara Makoto, Kähler Katharina C, Seggewiss-Bernhardt Ruth, Harvey Catriona, Long Georgina V, Schöberl Florian, von Baumgarten Louisa, Hundsberger Thomas, Schlaak Max, French Lars E, Knauss Samuel, Heinzerling Lucie M
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Müller-Jensen L, Zierold S, Versluis J, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank C, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel J, Ugurel S, Zimmer L, Banks P, Spain L, Soon J, Enokida T, Tahara M, Kähler K, Seggewiss-Bernhardt R, Harvey C, Long G, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French L, Knauss S, Heinzerling L. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study. Eur J Cancer 2022; 175:224-235.
Sep 22, 2022Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Sep 22, 2022Eur J Cancer 2022; 175:224-235
Müller-Jensen Leonie, Zierold Sarah, Versluis Judith M, Boehmerle Wolfgang, Huehnchen Petra, Endres Matthias, Mohr Raphael, Compter Annette, Blank Christian U, Hagenacker Tim, Meier Friedegund, Reinhardt Lydia, Gesierich Anja, Salzmann Martin, Hassel Jessica C, Ugurel Selma, Zimmer Lisa, Banks Patricia, Spain Lavinia, Soon Jennifer A, Enokida Tomohiro, Tahara Makoto, Kähler Katharina C, Seggewiss-Bernhardt Ruth, Harvey Catriona, Long Georgina V, Schöberl Florian, von Baumgarten Louisa, Hundsberger Thomas, Schlaak Max, French Lars E, Knauss Samuel, Heinzerling Lucie M
Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Jakeman B, Scherrer A, Darling K, Damas J, Bieler-Aeschlimann M, Hasse B, Schlosser L, Hachfeld A, Gutbrod K, Tarr P, Calmy A, Assal F, Kunze U, Stoeckle M, Schmid P, Rossi S, Di Benedetto C, Du Pasquier R, Cavassini M, Marzolini C, Hundsberger T. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus. Open Forum Infect Dis 2022; 9:ofac457.
Sep 2, 2022Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus.
Sep 2, 2022Open Forum Infect Dis 2022; 9:ofac457
Jakeman Bernadette, Scherrer Alexandra U, Darling Katharine E A, Damas José, Bieler-Aeschlimann Melanie, Hasse Barbara, Schlosser Ladina, Hachfeld Anna, Gutbrod Klemens, Tarr Philip E, Calmy Alexandra, Assal Frédéric, Kunze Ursula, Stoeckle Marcel, Schmid Patrick, Rossi Stefania, Di Benedetto Caroline, Du Pasquier Renaud, Cavassini Matthias, Marzolini Catia, Hundsberger Thomas
Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging.
van der Linde J, Jenny C, Hundsberger T, Broser P. Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging. Brain Behav 2022; 12:e2649.
Jul 10, 2022Correlation of age and the diameter of the cervical nerve roots C5 and C6 during the first 2 years of life analyzed by high-resolution ultrasound imaging.
Jul 10, 2022Brain Behav 2022; 12:e2649
van der Linde Jacoba, Jenny Carole, Hundsberger Thomas, Broser Philip
Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
Roelcke U, Schwyzer L, Zeitlberger A, Hundsberger T. Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression. Oncology 2022; 101:145-152.
Jul 1, 2022Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression.
Jul 1, 2022Oncology 2022; 101:145-152
Roelcke Ulrich, Schwyzer Lucia, Zeitlberger Anna Maria, Hundsberger Thomas
Peripheral neuropathy following COVID-19 mRNA vaccination – 2 Case Reports
Dorin P, Leupold D, Felbecker A, Hundsberger T (2022). Peripheral neuropathy following COVID-19 mRNA vaccination – 2 Case Reports.
Jun 25, 2022Peripheral neuropathy following COVID-19 mRNA vaccination – 2 Case Reports
Jun 25, 20228th EAN Congress
Dorin Patrick, Leupold Daniela, Felbecker Ansgar, Hundsberger Thomas
Postoperative radiotherapy for meningiomas - a decision-making analysis.
Fischer G, Brügge D, Andratschke N, Baumert B, Bosetti D, Caparrotti F, Herrmann E, Papachristofilou A, Rogers S, Schwyzer L, Zwahlen D, Hundsberger T, Putora P. Postoperative radiotherapy for meningiomas - a decision-making analysis. BMC cancer 2022; 22:492.
May 4, 2022Postoperative radiotherapy for meningiomas - a decision-making analysis.
May 4, 2022BMC cancer 2022; 22:492
Fischer Galina Farina, Brügge Detlef, Andratschke Nicolaus, Baumert Brigitta Gertrud, Bosetti Davide Giovanni, Caparrotti Francesca, Herrmann Evelyn, Papachristofilou Alexandros, Rogers Susanne, Schwyzer Lucia, Zwahlen Daniel Rudolf, Hundsberger Thomas, Putora Paul Martin